Chemomab Therapeutics(CMMB) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist

1.239
-0.041-3.18%

Trading Mar 24 11:00 ET

23.37MMarket Cap-1.44P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Chemomab Therapeutics Updates ADS Offering Under Sales Agreement
TipRanksMar 20 17:54 ET
Chemomab Therapeutics (CMMB) Gets a Buy From Oppenheimer
TipRanksMar 4 08:15 ET · Ratings
Chemomab Therapeutics Sees Cash Runway Through 1Q26
TipRanksMar 3 08:05 ET
Chemomab Therapeutics 4Q EPS 0.8c >CMMB
Dow JonesMar 3 08:05 ET
Express News | Chemomab Therapeutics Ltd: Q4 Shr Loss Less Than $0.01
ReutersMar 3 08:03 ET
Express News | Chemomab Therapeutics Q4 Operating Expenses USD 3.213 Million
ReutersMar 3 08:00 ET

Comments

Trytosaveabit

Mar 21 05:19

Reminder! Should be coming soon?

$Chemomab Therapeutics (CMMB.US)$ On Track for Releasing Clinical Data from SPRING Trial Open Label Extension in First Quarter 2025

Secrecity

Feb 20 01:39

$Chemomab Therapeutics (CMMB.US)$ let it rip

Teddy123

Feb 19 20:30

Clinical research Analysis

$Chemomab Therapeutics (CMMB.US)$
The FDA's agreement to Chemomab's innovative Phase 3 trial design for nebokitug represents a groundbreaking development in PSC drug development. This is the first time the FDA has accepted clinical events as primary endpoints for PSC treatment approval, marking a paradigm shift from traditional approaches that relied heavily on surrogate markers and liver biopsies.
The streamlined approval pathway through a single Phase 3 trial has seve...

Teddy123

Feb 19 20:29

Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis

$Chemomab Therapeutics (CMMB.US)$
FDA Fast-Tracks Revolutionary PSC Drug: Single Phase 3 Trial Could Change Rare Disease Treatment

Trytosaveabit

Feb 19 20:08

news

$Chemomab Therapeutics (CMMB.US)$ Reuters· 4 mins ago
Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns With FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (Cm-101) in Primary Sclerosing Cholangitis

Market Insights

Symbol Mini Chart % Chg

Unlock the Full List